Finoriq research workspace
Apellis Pharmaceuticals, Inc. (APLS) Historical Metrics
Review reported fundamentals, derived ratios, valuation context, and historical charts for Apellis Pharmaceuticals, Inc. (APLS).
Company Snapshot
- Company
- Apellis Pharmaceuticals, Inc. (APLS)
- Ticker
- APLS
- Market Cap
- $5.3B
- Latest Price
- $41.03
- Industry
- Biotech & Pharma
Apellis Pharmaceuticals, Inc. (APLS) Current Valuation Metrics
Static valuation preview for Apellis Pharmaceuticals, Inc. (APLS). Market data retrieved 2026-05-14. Filing currency USD.
| Metric | Value | Source |
|---|---|---|
| P/EMarket cap divided by latest TTM net income. | 39.4x | Net Income | TTM Q1 2026 |
| P/SMarket cap divided by latest TTM revenue. | 4.75x | Revenue | TTM Q1 2026 |
| P/Operating Cash FlowMarket cap divided by latest TTM operating cash flow. | 139x | Operating Cash Flow | TTM Q1 2026 |
| Earnings YieldLatest TTM net income divided by market cap. | 2.5% | Net Income | TTM Q1 2026 |
| Operating Cash Flow YieldLatest TTM operating cash flow divided by market cap. | 0.72% | Operating Cash Flow | TTM Q1 2026 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.